Coronary interventions
A Randomized, Intercontinental, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with de novo Coronary Artery Lesions BIOFLOW IV – Primary Outcome Target Vessel Failure at 12 Months. June 25, 2019 | 10.4244/EIJ-D-18-01214
